Pfeffer Cary 4
4 · Jounce Therapeutics, Inc. · Filed Nov 16, 2021
Insider Transaction Report
Form 4
Pfeffer Cary
Director
Transactions
- Sale
Common Stock
2021-11-12−0→ 0 total(indirect: See Footnote)
Holdings
- 0(indirect: See Footnote)
Common Stock
- 50,468
Common Stock
Footnotes (4)
- [F1]On November 12, 2021, Third Rock Ventures III, L.P. ("TRV III") sold 1,900,000 shares of Common Stock of the Issuer at an average price per share of $8.38.
- [F2]After the above transaction, TRV III owned 1,148,780 shares of Common Stock of the Issuer.
- [F3]The Reporting Person is a partner of Third Rock Ventures GP III, L.P., which is the general partner of TRV III. The Reporting Person disclaims beneficial ownership over the shares held by TRV III, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares.
- [F4]Third Rock Ventures II, L.P. ("TRV II") directly holds 2,697,829 shares of the Issuer's Common Stock. The Reporting Person is a partner of Third Rock Ventures GP II, L.P., which is the general partner of TRV II. The Reporting Person disclaims beneficial ownership over the shares held by TRV II, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares.